Expression of SAA and amyloidogenesis in congenic mice of CE/J and C57BL/6 strains

Lishan Wang, Juris J. Liepnieks, Merrill Benson, Barbara Kluve-Beckerman

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Inbred strains of mice display different susceptibilities to experimental induction of reactive amyloidosis. CBA/J, C57BL/6, and ICR are among the most susceptible strains, while CE/J mice appear to be totally resistant. In contrast to amyloidogenic strains which express two major acute phase serum amyloid A proteins (SAA1 and SAA2), CE/J mice produce only a single isoform, designated SAA2.2. Studies indicate that CE/J x CBA/J hybrid mice expressing both SAA2.2 and SAA1.1/SAA2.1 are amyloid resistant, and this has led to the hypothesis that SAA2.2 may protect mice against amyloid formation even in the presence of fibrillogenic SAA1.1. We have tested this hypothesis in mice derived from CE/J and C57BL/6 strains. CE/J mice were mated with C57BL/6 mice to produce F1 hybrids. Congenic mice were then produced by backcrossing each successive generation to C57BL/6 mice. Representative mice from F2 and F3 generations were analyzed to determine SAA genotype and susceptibility to amyloid induction by repeated casein injections. All F2 and F3 mice examined, including those which carried the SAA2.2 gene, developed extensive splenic AA amyloid. Expression of SAA2.2 in mice testing positive for the SAA2.2 gene was confirmed by sequence analysis of HDL-associated SAA proteins. These results demonstrate that the presence of SAA2.2 is not sufficient to protect CE/J x C57BL/6 hybrid mice from amyloid development. This is consistent with our observation that macrophage cultures, derived from C57BL/6, CBA/J, or CE/J mice, undergo amyloid deposition when treated with SAA1.1 alone or with equal amounts of SAA1.1 and SAA2.2, but show no deposition when treated solely with SAA2.2. We conclude from these studies that while SAA2.2 is non-fibrillogenic, its physical presence is not sufficient for protection against amyloid formation.

Original languageEnglish
Pages (from-to)26-31
Number of pages6
JournalAmyloid
Volume7
Issue number1
StatePublished - 2000

Fingerprint

Congenic Mice
Amyloid
Inbred C57BL Mouse
Serum Amyloid A Protein
Inbred Strains Mice
Inbreeding
Amyloidosis
Caseins
Genes
Sequence Analysis
Protein Isoforms
Macrophages

Keywords

  • AA amyloidosis
  • C57BL/6
  • Fibril formation
  • Mouse strains CE/J
  • Serum amyloid A

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medicine(all)

Cite this

Wang, L., Liepnieks, J. J., Benson, M., & Kluve-Beckerman, B. (2000). Expression of SAA and amyloidogenesis in congenic mice of CE/J and C57BL/6 strains. Amyloid, 7(1), 26-31.

Expression of SAA and amyloidogenesis in congenic mice of CE/J and C57BL/6 strains. / Wang, Lishan; Liepnieks, Juris J.; Benson, Merrill; Kluve-Beckerman, Barbara.

In: Amyloid, Vol. 7, No. 1, 2000, p. 26-31.

Research output: Contribution to journalArticle

Wang, L, Liepnieks, JJ, Benson, M & Kluve-Beckerman, B 2000, 'Expression of SAA and amyloidogenesis in congenic mice of CE/J and C57BL/6 strains', Amyloid, vol. 7, no. 1, pp. 26-31.
Wang, Lishan ; Liepnieks, Juris J. ; Benson, Merrill ; Kluve-Beckerman, Barbara. / Expression of SAA and amyloidogenesis in congenic mice of CE/J and C57BL/6 strains. In: Amyloid. 2000 ; Vol. 7, No. 1. pp. 26-31.
@article{49b56e38d716474b8abf669f148b2a7f,
title = "Expression of SAA and amyloidogenesis in congenic mice of CE/J and C57BL/6 strains",
abstract = "Inbred strains of mice display different susceptibilities to experimental induction of reactive amyloidosis. CBA/J, C57BL/6, and ICR are among the most susceptible strains, while CE/J mice appear to be totally resistant. In contrast to amyloidogenic strains which express two major acute phase serum amyloid A proteins (SAA1 and SAA2), CE/J mice produce only a single isoform, designated SAA2.2. Studies indicate that CE/J x CBA/J hybrid mice expressing both SAA2.2 and SAA1.1/SAA2.1 are amyloid resistant, and this has led to the hypothesis that SAA2.2 may protect mice against amyloid formation even in the presence of fibrillogenic SAA1.1. We have tested this hypothesis in mice derived from CE/J and C57BL/6 strains. CE/J mice were mated with C57BL/6 mice to produce F1 hybrids. Congenic mice were then produced by backcrossing each successive generation to C57BL/6 mice. Representative mice from F2 and F3 generations were analyzed to determine SAA genotype and susceptibility to amyloid induction by repeated casein injections. All F2 and F3 mice examined, including those which carried the SAA2.2 gene, developed extensive splenic AA amyloid. Expression of SAA2.2 in mice testing positive for the SAA2.2 gene was confirmed by sequence analysis of HDL-associated SAA proteins. These results demonstrate that the presence of SAA2.2 is not sufficient to protect CE/J x C57BL/6 hybrid mice from amyloid development. This is consistent with our observation that macrophage cultures, derived from C57BL/6, CBA/J, or CE/J mice, undergo amyloid deposition when treated with SAA1.1 alone or with equal amounts of SAA1.1 and SAA2.2, but show no deposition when treated solely with SAA2.2. We conclude from these studies that while SAA2.2 is non-fibrillogenic, its physical presence is not sufficient for protection against amyloid formation.",
keywords = "AA amyloidosis, C57BL/6, Fibril formation, Mouse strains CE/J, Serum amyloid A",
author = "Lishan Wang and Liepnieks, {Juris J.} and Merrill Benson and Barbara Kluve-Beckerman",
year = "2000",
language = "English",
volume = "7",
pages = "26--31",
journal = "Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis",
issn = "1350-6129",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Expression of SAA and amyloidogenesis in congenic mice of CE/J and C57BL/6 strains

AU - Wang, Lishan

AU - Liepnieks, Juris J.

AU - Benson, Merrill

AU - Kluve-Beckerman, Barbara

PY - 2000

Y1 - 2000

N2 - Inbred strains of mice display different susceptibilities to experimental induction of reactive amyloidosis. CBA/J, C57BL/6, and ICR are among the most susceptible strains, while CE/J mice appear to be totally resistant. In contrast to amyloidogenic strains which express two major acute phase serum amyloid A proteins (SAA1 and SAA2), CE/J mice produce only a single isoform, designated SAA2.2. Studies indicate that CE/J x CBA/J hybrid mice expressing both SAA2.2 and SAA1.1/SAA2.1 are amyloid resistant, and this has led to the hypothesis that SAA2.2 may protect mice against amyloid formation even in the presence of fibrillogenic SAA1.1. We have tested this hypothesis in mice derived from CE/J and C57BL/6 strains. CE/J mice were mated with C57BL/6 mice to produce F1 hybrids. Congenic mice were then produced by backcrossing each successive generation to C57BL/6 mice. Representative mice from F2 and F3 generations were analyzed to determine SAA genotype and susceptibility to amyloid induction by repeated casein injections. All F2 and F3 mice examined, including those which carried the SAA2.2 gene, developed extensive splenic AA amyloid. Expression of SAA2.2 in mice testing positive for the SAA2.2 gene was confirmed by sequence analysis of HDL-associated SAA proteins. These results demonstrate that the presence of SAA2.2 is not sufficient to protect CE/J x C57BL/6 hybrid mice from amyloid development. This is consistent with our observation that macrophage cultures, derived from C57BL/6, CBA/J, or CE/J mice, undergo amyloid deposition when treated with SAA1.1 alone or with equal amounts of SAA1.1 and SAA2.2, but show no deposition when treated solely with SAA2.2. We conclude from these studies that while SAA2.2 is non-fibrillogenic, its physical presence is not sufficient for protection against amyloid formation.

AB - Inbred strains of mice display different susceptibilities to experimental induction of reactive amyloidosis. CBA/J, C57BL/6, and ICR are among the most susceptible strains, while CE/J mice appear to be totally resistant. In contrast to amyloidogenic strains which express two major acute phase serum amyloid A proteins (SAA1 and SAA2), CE/J mice produce only a single isoform, designated SAA2.2. Studies indicate that CE/J x CBA/J hybrid mice expressing both SAA2.2 and SAA1.1/SAA2.1 are amyloid resistant, and this has led to the hypothesis that SAA2.2 may protect mice against amyloid formation even in the presence of fibrillogenic SAA1.1. We have tested this hypothesis in mice derived from CE/J and C57BL/6 strains. CE/J mice were mated with C57BL/6 mice to produce F1 hybrids. Congenic mice were then produced by backcrossing each successive generation to C57BL/6 mice. Representative mice from F2 and F3 generations were analyzed to determine SAA genotype and susceptibility to amyloid induction by repeated casein injections. All F2 and F3 mice examined, including those which carried the SAA2.2 gene, developed extensive splenic AA amyloid. Expression of SAA2.2 in mice testing positive for the SAA2.2 gene was confirmed by sequence analysis of HDL-associated SAA proteins. These results demonstrate that the presence of SAA2.2 is not sufficient to protect CE/J x C57BL/6 hybrid mice from amyloid development. This is consistent with our observation that macrophage cultures, derived from C57BL/6, CBA/J, or CE/J mice, undergo amyloid deposition when treated with SAA1.1 alone or with equal amounts of SAA1.1 and SAA2.2, but show no deposition when treated solely with SAA2.2. We conclude from these studies that while SAA2.2 is non-fibrillogenic, its physical presence is not sufficient for protection against amyloid formation.

KW - AA amyloidosis

KW - C57BL/6

KW - Fibril formation

KW - Mouse strains CE/J

KW - Serum amyloid A

UR - http://www.scopus.com/inward/record.url?scp=0034110875&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034110875&partnerID=8YFLogxK

M3 - Article

C2 - 10842702

AN - SCOPUS:0034110875

VL - 7

SP - 26

EP - 31

JO - Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

JF - Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

SN - 1350-6129

IS - 1

ER -